Suppr超能文献

tau 病中的固有免疫反应。

The innate immune response in tauopathies.

机构信息

Center for Brain Immunology and Glia (BIG), Department of Neuroscience, University of Virginia, Charlottesville, VA, USA.

Neuroscience Graduate Program, University of Virginia, Charlottesville, VA, USA.

出版信息

Eur J Immunol. 2023 Jun;53(6):e2250266. doi: 10.1002/eji.202250266. Epub 2023 May 4.

Abstract

Tauopathies, which include frontotemporal dementia, Alzheimer's disease, and chronic traumatic encephalopathy, are a class of neurological disorders resulting from pathogenic tau aggregates. These aggregates disrupt neuronal health and function leading to the cognitive and physical decline of tauopathy patients. Genome-wide association studies and clinical evidence have brought to light the large role of the immune system in inducing and driving tau-mediated pathology. More specifically, innate immune genes are found to harbor tauopathy risk alleles, and innate immune pathways are upregulated throughout the course of disease. Experimental evidence has expanded on these findings by describing pivotal roles for the innate immune system in the regulation of tau kinases and tau aggregates. In this review, we summarize the literature implicating innate immune pathways as drivers of tauopathy.

摘要

tau 病包括额颞叶痴呆、阿尔茨海默病和慢性创伤性脑病,是一类由致病性 tau 聚集物引起的神经退行性疾病。这些聚集物破坏神经元的健康和功能,导致 tau 病患者的认知和身体功能下降。全基因组关联研究和临床证据表明,免疫系统在诱导和驱动 tau 介导的病理方面起着重要作用。更具体地说,先天免疫基因被发现含有 tau 病风险等位基因,先天免疫途径在疾病过程中被上调。实验证据通过描述先天免疫系统在调节 tau 激酶和 tau 聚集物方面的关键作用扩展了这些发现。在这篇综述中,我们总结了将先天免疫途径作为 tau 病驱动因素的文献。

相似文献

1
The innate immune response in tauopathies.
Eur J Immunol. 2023 Jun;53(6):e2250266. doi: 10.1002/eji.202250266. Epub 2023 May 4.
2
Complement receptor 4 mediates the clearance of extracellular tau fibrils by microglia.
FEBS J. 2024 Aug;291(15):3499-3520. doi: 10.1111/febs.17150. Epub 2024 May 7.
3
AlphaScreen Identifies MSUT2 Inhibitors for Tauopathy-Targeting Therapeutic Discovery.
SLAS Discov. 2021 Mar;26(3):400-409. doi: 10.1177/2472555220958387. Epub 2020 Sep 28.
4
Tau Seeding Mouse Models with Patient Brain-Derived Aggregates.
Int J Mol Sci. 2021 Jun 7;22(11):6132. doi: 10.3390/ijms22116132.
6
A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
Exp Neurol. 2008 Jul;212(1):71-84. doi: 10.1016/j.expneurol.2008.03.007. Epub 2008 Mar 21.
7
Syntaxins 6 and 8 facilitate tau into secretory pathways.
Biochem J. 2021 Apr 16;478(7):1471-1484. doi: 10.1042/BCJ20200664.
8
Genetic and sporadic forms of tauopathies-TAU as a disease driver for the majority of patients but the minority of tauopathies.
Cytoskeleton (Hoboken). 2024 Jan;81(1):66-70. doi: 10.1002/cm.21793. Epub 2023 Oct 5.
9
The Prion-Like Behavior of Assembled Tau in Transgenic Mice.
Cold Spring Harb Perspect Med. 2017 Oct 3;7(10):a024372. doi: 10.1101/cshperspect.a024372.
10
Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease.
Adv Exp Med Biol. 2019;1184:145-166. doi: 10.1007/978-981-32-9358-8_13.

引用本文的文献

2
STING deletion protects against amyloid β-induced Alzheimer's disease pathogenesis.
Alzheimers Dement. 2025 May;21(5):e70305. doi: 10.1002/alz.70305.
4
Immunity in neuromodulation: probing neural and immune pathways in brain disorders.
J Neuroinflammation. 2025 Apr 28;22(1):122. doi: 10.1186/s12974-025-03440-4.
6
From defense to disease: IFITM3 in immunity and Alzheimer's disease.
Neurotherapeutics. 2025 Apr;22(3):e00482. doi: 10.1016/j.neurot.2024.e00482. Epub 2024 Nov 8.
7
Cellular and pathological functions of tau.
Nat Rev Mol Cell Biol. 2024 Nov;25(11):845-864. doi: 10.1038/s41580-024-00753-9. Epub 2024 Jul 16.
9
Tau induces inflammasome activation and microgliosis through acetylating NLRP3.
Clin Transl Med. 2024 Mar;14(3):e1623. doi: 10.1002/ctm2.1623.
10
Galectin-3 is upregulated in frontotemporal dementia patients with subtype specificity.
Alzheimers Dement. 2024 Mar;20(3):1515-1526. doi: 10.1002/alz.13536. Epub 2023 Nov 29.

本文引用的文献

1
Virus exposure and neurodegenerative disease risk across national biobanks.
Neuron. 2023 Apr 5;111(7):1086-1093.e2. doi: 10.1016/j.neuron.2022.12.029. Epub 2023 Jan 19.
2
Brain borders at the central stage of neuroimmunology.
Nature. 2022 Dec;612(7940):417-429. doi: 10.1038/s41586-022-05474-7. Epub 2022 Dec 14.
3
Pyroptosis in Alzheimer's disease: cell type-specific activation in microglia, astrocytes and neurons.
Acta Neuropathol. 2023 Feb;145(2):175-195. doi: 10.1007/s00401-022-02528-y. Epub 2022 Dec 9.
4
Microglia states and nomenclature: A field at its crossroads.
Neuron. 2022 Nov 2;110(21):3458-3483. doi: 10.1016/j.neuron.2022.10.020.
5
The emerging role of autophagy and mitophagy in tauopathies: From pathogenesis to translational implications in Alzheimer's disease.
Front Aging Neurosci. 2022 Oct 17;14:1022821. doi: 10.3389/fnagi.2022.1022821. eCollection 2022.
6
TREM2 drives microglia response to amyloid-β via SYK-dependent and -independent pathways.
Cell. 2022 Oct 27;185(22):4153-4169.e19. doi: 10.1016/j.cell.2022.09.033.
7
SYK coordinates neuroprotective microglial responses in neurodegenerative disease.
Cell. 2022 Oct 27;185(22):4135-4152.e22. doi: 10.1016/j.cell.2022.09.030. Epub 2022 Oct 17.
8
CSF glial markers are elevated in a subset of patients with genetic frontotemporal dementia.
Ann Clin Transl Neurol. 2022 Nov;9(11):1764-1777. doi: 10.1002/acn3.51672. Epub 2022 Oct 17.
9
Dementia-related genetic variants in an Italian population of early-onset Alzheimer's disease.
Front Aging Neurosci. 2022 Sep 5;14:969817. doi: 10.3389/fnagi.2022.969817. eCollection 2022.
10
How the immune system shapes neurodegenerative diseases.
Trends Neurosci. 2022 Oct;45(10):733-748. doi: 10.1016/j.tins.2022.08.001. Epub 2022 Sep 5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验